ANAB
ANAB
US0327241065
AnaptysBio, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.37B EUR
1.07B EUR
905.57M EUR
Enterprise Value
1.49B EUR
838.51M EUR
781.49M EUR
Valuation Multiples
Trailing P/E
--
--
--
Forward P/E
9.07x
--
--
Price to Sales
12.95x
4.62x
3.86x
Price to Book
129.07x
84.21x
24.34x
EV/Revenue
14.02x
3.61x
3.33x
EV/EBITDA
22.63x
14.34x
11.29x
Price to FCF (P/FCF)
--
243.45x
46.18x
EV/FCF
--
190.18x
39.85x
FCF Yield
--
0.41%
2.17%
ende